scPharmaceuticals Inc (NASDAQ: SCPH) is 10.73% higher on its value in year-to-date trading and has touched a low of $1.94 and a high of $5.65 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SCPH stock was last observed hovering at around $3.99 in the last trading session, with the day’s loss setting it -0.07%.
Currently trading at $3.92, the stock is 1.77% and 27.76% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.14 million and changing -1.75% at the moment leaves the stock 10.14% off its SMA200. SCPH registered -5.31% loss for a year compared to 6-month gain of 22.88%.
The stock witnessed a 11.36% loss in the last 1 month and extending the period to 3 months gives it a 28.95%, and is -3.92% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.25% over the week and 3.31% over the month.
scPharmaceuticals Inc (SCPH) has around 164 employees, a market worth around $206.94M and $41.98M in sales. Profit margin for the company is -216.24%. Distance from 52-week low is 102.06% and -30.62% from its 52-week high. The company has generated returns on investments over the last 12 months (-193.25%).
The EPS is expected to grow by 45.01% this year
The shares outstanding are 50.28M, and float is at 35.96M with Short Float at 5.78%.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 5.56 million shares valued at $24.18 million. The investor’s holdings represent 14.2608 of the SCPH Shares outstanding. As of 2024-06-30, the second largest holder is RUBRIC CAPITAL MANAGEMENT LP with 3.52 million shares valued at $15.33 million to account for 9.042 of the shares outstanding. The other top investors are AIGH CAPITAL MANAGEMENT LLC which holds 3.5 million shares representing 8.9891 and valued at over $15.24 million, while KING LUTHER CAPITAL MANAGEMENT CORP holds 5.6564 of the shares totaling 2.21 million with a market value of $9.59 million.
scPharmaceuticals Inc (SCPH) Insider Activity
The most recent transaction is an insider purchase by ORBIMED ADVISORS LLC, the company’s 10% Owner. SEC filings show that ORBIMED ADVISORS LLC bought 500,000 shares of the company’s common stock on Aug 13 ’24 at a price of $4.00 per share for a total of $2.0 million. Following the purchase, the insider now owns 5.81 million shares.
